ACE and Nephropathy: Another study from Jacobsen et al. [47], which included 169 IDDM patients with overt nephropathy, showed that the D allele of the ACE I/D polymorphism in addition to nongenetic risk factors independently accelerated progression of diabetic nephropathy during ACE inhibition.